CIK 0001821586 · Large accelerated filer
MoonLake Immunotherapeutics
Sign in to watch- Ticker
- MLTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Cayman Islands
- Entity type
- operating
- Phone
- 41 41 510 8022
- Business address
- DORFSTRASSE 29, ZUG, Switzerland, 6300
- Former names
- Helix Acquisition Corp
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Other events
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- S-8 Other Securities Offered to Employees in Benefit Plans
- S-3ASR Offering Registration Statement
- 10-Q Report Quarterly Report
- 8-K Event Results of operations · Regulation FD disclosure
- 4 Planned sale Chief Scientific Officer sold 1,100 shares at $20.00 ($22,000)
- 4 Planned sale Chief Scientific Officer sold 52,448 shares at an average $20.02 ($1,049,960)
- 4 Planned sale Chief Scientific Officer sold 43,700 shares at $20.09 ($877,933)
- 4 Planned sale Chief Scientific Officer sold 16,105 shares at $20.01 ($322,261)
- 144 Insider Sale of Securities
- 8-K Event Other events
- 4 Planned sale Chief Executive Officer sold 102,225 shares at an average $20.02 ($2,046,205)
- 4 Planned sale Chief Executive Officer sold 47,775 shares at $20.03 ($956,933)
- 144 Insider Sale of Securities
- SCHEDULE 13D/A Stake Beneficial Ownership Report
Page 1 of 17 · 331 filings